(CLMT) Calumet Specialty Products - Ratings and Ratios
Solvents, Waxes, Lubricants, Renewable Diesel, Aviation Fuel
CLMT EPS (Earnings per Share)
CLMT Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 43.7% |
| Value at Risk 5%th | 64.2% |
| Relative Tail Risk | -10.65% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.08 |
| Alpha | -34.94 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.537 |
| Beta | 1.385 |
| Beta Downside | 2.440 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.87% |
| Mean DD | 20.85% |
| Median DD | 19.65% |
Description: CLMT Calumet Specialty Products November 12, 2025
Calumet Specialty Products Partners (NASDAQ: CLMT) manufactures and markets a diversified portfolio of specialty chemicals, branded performance products, and renewable fuels across North America and select international markets. The company operates through three segments: Specialty Products & Solutions (solvents, waxes, custom lubricants, etc.), Montana/Renewables (renewable diesel, sustainable aviation fuel, renewable hydrogen, and conventional refined products from Canadian crude), and Performance Brands (Royal Purple, Bel-Ray, TruFuel). Founded in 1919 and headquartered in Indianapolis, Indiana, Calumet leverages its integrated refining footprint to serve both industrial and consumer-facing customers.
Key recent metrics (FY 2023): revenue of roughly **$1.5 billion**, adjusted EBITDA margin of **≈12 %**, and a renewable fuel production capacity of **≈200,000 barrels per day** (primarily renewable diesel). The Montana/Renewables segment contributed about **55 %** of total revenue, reflecting the growing market share of low-carbon fuels.
Primary economic drivers include the U.S. **Renewable Fuel Standard (RFS) credits**, which boost margins on renewable diesel, and the **low-carbon aviation fuel mandates** that are expanding demand for sustainable aviation fuel. Additionally, macro-level fuel price volatility and the broader industry shift toward decarbonization are likely to influence both the volume and pricing dynamics of Calumet’s conventional and renewable product lines.
For a deeper quantitative assessment, the ValueRay platform offers granular financial metrics and scenario analysis that may help you evaluate CLMT’s upside potential.
CLMT Stock Overview
| Market Cap in USD | 1,665m |
| Sub-Industry | Oil & Gas Refining & Marketing |
| IPO / Inception | 2006-01-26 |
| Return 12m vs S&P 500 | -19.2% |
| Analyst Rating | 3.86 of 5 |
CLMT Dividends
Currently no dividends paidCLMT Growth Ratios
| CAGR 3y | 2.23% |
| CAGR/Max DD Calmar Ratio | 0.04 |
| CAGR/Mean DD Pain Ratio | 0.11 |
| Current Volume | 1438.1k |
| Average Volume | 811k |
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income (-37.2m TTM) > 0 and > 6% of Revenue (6% = 242.9m TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA 2.30pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 2.56% (prev -11.02%; Δ 13.58pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.00 (>3.0%) and CFO -11.0m > Net Income -37.2m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (86.7m) change vs 12m ago 1.38% (target <= -2.0% for YES) |
| Gross Margin 8.21% (prev 4.01%; Δ 4.20pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 150.7% (prev 159.7%; Δ -9.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.41 (EBITDA TTM -182.2m / Interest Expense TTM 449.2m) >= 6 (WARN >= 3) |
Altman Z'' -2.55
| (A) 0.04 = (Total Current Assets 880.1m - Total Current Liabilities 776.3m) / Total Assets 2.73b |
| (B) -0.56 = Retained Earnings (Balance) -1.54b / Total Assets 2.73b |
| (C) -0.07 = EBIT TTM -182.2m / Avg Total Assets 2.69b |
| (D) -0.48 = Book Value of Equity -1.54b / Total Liabilities 3.18b |
| Total Rating: -2.55 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 23.38
| 1. Piotroski 0.0pt = -5.0 |
| 2. FCF Yield -4.38% = -2.19 |
| 3. FCF Margin -1.87% = -0.70 |
| 4. Debt/Equity -0.22 = -2.50 |
| 5. Debt/Ebitda -0.33 = -2.50 |
| 6. ROIC - WACC (= -24.52)% = -12.50 |
| 7. RoE 4.54% = 0.38 |
| 8. Rev. Trend 1.90% = 0.14 |
| 9. EPS Trend -35.00% = -1.75 |
What is the price of CLMT shares?
Over the past week, the price has changed by -6.15%, over one month by +0.16%, over three months by +28.13% and over the past year by -7.99%.
Is Calumet Specialty Products a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLMT is around 16.44 USD . This means that CLMT is currently overvalued and has a potential downside of -10.21%.
Is CLMT a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CLMT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.3 | 10.6% |
| Analysts Target Price | 20.3 | 10.6% |
| ValueRay Target Price | 18.5 | 1% |
CLMT Fundamental Data Overview November 10, 2025
P/E Forward = 11.3507
P/S = 0.4113
P/B = 19.3228
P/EG = 2.71
Beta = 1.179
Revenue TTM = 4.05b USD
EBIT TTM = -182.2m USD
EBITDA TTM = -182.2m USD
Long Term Debt = 2.06b USD (from longTermDebt, last fiscal year)
Short Term Debt = 155.2m USD (from shortTermDebt, last quarter)
Debt = 155.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 60.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.73b USD (1.66b + Debt 155.2m - CCE 94.6m)
Interest Coverage Ratio = -0.41 (Ebit TTM -182.2m / Interest Expense TTM 449.2m)
FCF Yield = -4.38% (FCF TTM -75.6m / Enterprise Value 1.73b)
FCF Margin = -1.87% (FCF TTM -75.6m / Revenue TTM 4.05b)
Net Margin = -0.92% (Net Income TTM -37.2m / Revenue TTM 4.05b)
Gross Margin = 8.21% ((Revenue TTM 4.05b - Cost of Revenue TTM 3.72b) / Revenue TTM)
Gross Margin QoQ = 34.67% (prev -4.25%)
Tobins Q-Ratio = 0.63 (Enterprise Value 1.73b / Total Assets 2.73b)
Interest Expense / Debt = 178.1% (Interest Expense 276.4m / Debt 155.2m)
Taxrate = -15.22% (negative due to tax credits) (-41.4m / 272.0m)
NOPAT = -209.9m (EBIT -182.2m * (1 - -15.22%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.13 (Total Current Assets 880.1m / Total Current Liabilities 776.3m)
Debt / Equity = -0.22 (negative equity) (Debt 155.2m / totalStockholderEquity, last quarter -695.3m)
Debt / EBITDA = -0.33 (negative EBITDA) (Net Debt 60.6m / EBITDA -182.2m)
Debt / FCF = -0.80 (negative FCF - burning cash) (Net Debt 60.6m / FCF TTM -75.6m)
Total Stockholder Equity = -819.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.36% (Net Income -37.2m / Total Assets 2.73b)
RoE = 4.54% (negative equity) (Net Income TTM -37.2m / Total Stockholder Equity -819.8m)
RoCE = -14.64% (EBIT -182.2m / Capital Employed (Equity -819.8m + L.T.Debt 2.06b))
RoIC = -15.04% (negative operating profit) (NOPAT -209.9m / Invested Capital 1.40b)
WACC = 9.48% (E(1.66b)/V(1.82b) * Re(10.36%) + (debt cost/tax rate unavailable))
Discount Rate = 10.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.00%
Fair Price DCF = unknown (Cash Flow -75.6m)
EPS Correlation: -35.00 | EPS CAGR: 28.66% | SUE: 0.66 | # QB: 0
Revenue Correlation: 1.90 | Revenue CAGR: 2.78% | SUE: 0.63 | # QB: 0
Additional Sources for CLMT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle